The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months' Evolution and Prior Immunosuppressive Treatment.

Cubiró, X

The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months' Evolution and Prior Immunosuppressive Treatment. [electronic resource] - Actas dermo-sifiliograficas May 2019 - 289-296 p. digital

Publication Type: Journal Article; Review

2173-5778

10.1016/j.ad.2018.09.009 doi


Adolescent
Adult
Aged
Anti-Allergic Agents--therapeutic use
Chronic Disease
Female
Histamine H1 Antagonists--therapeutic use
Humans
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Omalizumab--therapeutic use
Pragmatic Clinical Trials as Topic
Registries
Remission Induction
Retrospective Studies
Treatment Outcome
Urticaria--drug therapy
Young Adult